The European Commission has now announced six new calls for funding under the Cancer Mission. The following two are particularly relevant for researchers at The Faculty of Medicine:

Accessible and affordable tests to advance early detection of heritable cancers in European regions HORIZON-MISS-2024-CANCER-01-03. Innovation action 12 MIO EUR per project. To validate easy-to-use, affordable and accessible genetic, multi-omics or other biomarker-based cancer tests for early detection of cancers with an underlying heritable genetic risk. Activities are expected to achieve TRL 5 to 7 by the end of the project. ​​​​​​​

Improving the understanding and management of late-effects in adolescents and young adults (AYA) with cancer HORIZON-MISS-2024-CANCER-01-05. 6 MIO EUR per project. The focus should be exclusively on adolescent and young adult (AYA, age range 15-39) cancer patients and survivors.

Application Deadline: 18 September 2024 

 If these topics sound interesting, please contact the research advisers at MED for advise on how to build or join a consortium and apply: Application Support for External Funding | Faculty of Medicine | UiB

 You can also join the EU Info Days on 25 and 26 April to learn more about the calls: Events | The research and innovation community platform (europa.eu)